Dr. Jiralerspong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Arizona Cancer Center
1515 N Campbell Ave
Tucson, AZ 85724Phone+1 520-626-4331- Is this information wrong?
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2008
Boston University Medical CenterResidency, Internal Medicine, 2001 - 2004
Baylor College of MedicineClass of 2001
Harvard University
Certifications & Licensure
AZ State Medical License 2018 - 2025
TX State Medical License 2006 - 2019- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01
- Scalp Cooling to Prevent Chemo-induced Hair Loss Start of enrollment: 2014 May 15
- High Dose Vitamin D vs Standard Dose Vitamin D Study Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients.Jessica A Martinez, Betsy C Wertheim, Denise J Roe, Mihra S Taljanovic, H-H Sherry Chow, Wade Chew, Sima Ehsani, Sao Jiralerspong, Jennifer Segar, Pavani Chalasani> ;Metabolites. 2023 Mar 20
- 2 citationsFeasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias.Jessica A Martinez, Mihra S Taljanovic, Andres A Nuncio Zuniga, Betsy C Wertheim, Denise J Roe, Sima Ehsani, Sao Jiralerspong, Jennifer Segar, Pavani Chalasani> ;Journal of Clinical Medicine. 2022 Feb 18
- 10 citationsMetformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancerLei Xue, Fengju Chen, Fei Yue, Laura Camacho, Sushma Kothapalli, Guanyun Wei, Shixia Huang, Qianxing Mo, Fei Ma, Yi Li, Sao Jiralerspong> ;Breast Cancer Research and Treatment. 2021 Jan 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Banner - University Medical Center TucsonTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
